SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs acquires US FDA approved formulation manufacturing facility

01 Aug 2013 Evaluate

Vivimed Labs has acquired Actavis Pharma Manufacturing’s (APMPL) solid oral dosage facility in Alathur, Tamil Nadu for Rs 122 crore. The facility, which Vivimed acquired from APMPL’s parent Actavis Holding Asia BV, has already received the US Food and Drug Administration (US FDA) approval. 

Along with the facility, the company has also acquired two commercially valuable and marketable Abbreviated New Drug Applications (ANDAs) which will allow the company to generate additional revenues.

Vivimed Labs’s manufacturing unit is located at Bidar, Karnataka, where it was originally engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and bulk drugs like Ibuprofen etc.

Vivimed Labs Share Price

7.38 -0.26 (-3.40%)
21-Apr-2026 12:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1220.50
Cipla 1232.75
Zydus Lifesciences 927.80
Lupin 2321.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×